BSE Healthcare index stocks 30Apr20 Chart Strength 19Feb15 Chart Strength
Abbott India 1 strong  
Alembic Pharmaceuticals  10  
Alkem Laboratories 7  
Apollo Hospitals Enterprise 17 9
Aurobindo Pharma 16 15
Biocon 16
Cadila Healthcare 11  10
Cipla 8
Divi's Laboratories 14
Dr. Reddy's Laboratories 7
Fortis Healthcare 20  
GlaxoSmithKline Phar   12
Glenmark Pharmaceuticals 19  11
Granules India 13  
Hester Biosciences  18  
Ipca Laboratories 17
Lupin 1 strongest
Piramal Enterprises 21  2
Ranbaxy Laboratories   6
Strides Pharma 18  13
Sun Pharmaceutical I 14  3
Syngene International 12  
Torrent Pharma 5
Wockhardt   4

Note
All the above stocks form the BSE Health Care Index. 
Health Care Sector Index includes stocks from Pharmaceutical, Hospital, Biotech, Research & Development and other related industries.

  • Stocks trading above 200 day moving average  laughing
        Shares are shown in blue colour
  • Stocks trading below but close to 200 day moving average smile
        Shares are shown in orange colour
  • Stocks trading much below 200 day moving average frown
        Shares are shown in red colour

BSE Pharmaceutical Sector Trend

Out of 21 Pharmaceutical stocks 17 are trading above 200 day moving average. 
That means 81% of Pharmaceutical stocks are trading above 200-dma. 
Pharma like FMCG being a defensive sector outperforms other sectors in a falling market also.
Like IT companies Indian Pharma companies are also cashing on exports.

Outperformers: Abbott India, Ipca Laboratories, Biocon, Dr. Reddy's Lab, Cipla, Divi's Lab, Alkem Lab. 
Underperformers: Piramal Enterprises, Fortis Healthcare, Hester Biosciences, Apollo Hospitals.

 

2013 worldwide generic sales

Phama co.       $ bn

Teva                 9.2

Sandoz             8.2

Actavis              6.3

Mylan                5.9

Sun + Ranbaxy  4.3

Sun                   2.5

Hospira             2.4

Sanofi               2.2

Aspen               2.1

Ranbaxy           1.8

Lupin                1.8

 

Generic sale in India in last 12 months as of Feb 2014

Phama co.              Market                $ m

                             Share %

Sun + Ranbaxy       9.2                          1116

Abbott                   6.5                           783

Sun                       5.4                           651

Cipla                      5.0                           604

Cadila                    4.4                           538

Ranbaxy                 3.8                           465

GSK                       3.7                           447

Mankind                 3.6                           431

Alkem                    3.5                           423

Lupin                     3.3                           406

Pfizer                     3.0                           354

[Source: dna dated 8 April 2014]


Note
Click on view below to see 200, 100 and 50-dma 2 years chart with volume.
If 2 years chart is not seen click on 5d to see 5 days chart.

Related topics
Pharmaceutical – NSE
Pharmaceutical – MNC
Pharmaceutical – Others